Healthtech Startups

GeneLancet develops proprietary LgRNA technology for precise gene editing, with applications in CRISPR polymerase-directed therapies targeting neurodegenerative diseases and cancers with unmet medical needs.

1 investor

Genenta Science is a clinical-stage biotechnology company developing Temferon, a hematopoietic stem cell-based gene therapy platform for treating cancer. The company is publicly traded on Nasdaq under the ticker GNTA.

1 investor

Generable develops statistical and computational models for drug development and healthcare decision-making, leveraging Bayesian methods and probabilistic modeling. The company serves pharmaceutical and biotech organizations in developing safer and more efficient therapeutic interventions.

1 investor

General Biotechnologies manufactures peptide therapeutics by genetically programming edible microbes to synthesise molecules, aiming to produce them at lower cost. It focuses on reviving clinically proven but discontinued off-patent peptides as low-cost oral drugs, including an oral GLP-1, and partners with pharma companies to bring shelved assets back as oral formulations.

1 investor

General Inception is an operational support and company building firm that handles day-to-day planning and execution for building companies, with a focus on life science tools and diagnostics.

1 investor

GeneralPractice.AI is a platform for primary care clinicians that generates personalized prevention and lifestyle medicine plans during routine consultations. It helps GPs deliver structured, evidence-based management plans for chronic disease prevention and health optimization without adding administrative burden.

1 investor

Generate Life Sciences was a reproductive, newborn stem cell, and genetic services company offering products and services to help families grow and protect their families. It has been acquired by CooperSurgical.

1 investor

family.cards develops digital solutions to connect elderly Germans with their families and integrate them into digital channels. The company addresses the digital divide affecting 8 million seniors in Germany by creating intuitive, age-friendly technology platforms.

1 investor

Genesis Automation Healthcare provides a clinical lifecycle management platform that bridges the gap between ERP and EHR systems in healthcare organizations. The platform consolidates supply chain operations across hospital facilities to improve inventory management, patient safety, and financial performance.

1 investor

Adapsyn Bioscience is a biotechnology company that uses proprietary algorithms and artificial intelligence to analyze genomic and metabolomic data from microbes in order to discover novel small molecule natural product drug candidates.

1 investor

GeneTech provides non-invasive prenatal testing (NIPT) using fetal cell-free DNA from maternal blood, along with clinical laboratory testing services, offered to certified medical institutions in Japan. It introduced NIPT in Japan in 2013 and runs a domestic analysis lab, serving pregnant patients and their families through partner hospitals.

1 investor

Genetica is an artificial intelligence-powered genetic testing company that analyzes hundreds of genes to provide scientific insights about physical traits, behavior, intelligence, and health risks for Asian populations. The company partners with leading genome sequencing organizations and aims to optimize personal development plans and protect individual and family health.

1 investor

Geneticure offers a patented genetic test that uses a cheek-swab DNA sample, analyzing 17 genotypes across 11 genes to recommend personalized hypertension (blood pressure) treatment plans. The test helps doctors prescribe effective treatments by assessing the responsiveness of the patient's cardiac, vascular, and renal systems, reducing trial-and-error prescribing.

1 investor

GENEWIZ provides sequencing, synthesis, and molecular biology services for research, clinical, and therapeutic applications, serving academic institutions, biotech companies, and pharmaceutical organizations.

1 investor

GenHealth provides AI-based revenue cycle management and administrative automation for healthcare providers and DME teams, handling intake, eligibility, claims, prior authorization, denials, and appeals. Its browser agent extracts data from faxes and documents and routes it into EMR and billing systems, targeting independent physician groups and providers.

1 investor

GenieBiome (G-NiiB) develops microbiome-modifying technology and therapeutic candidates supported by clinical trials, using next-generation sequencing. The company focuses on treating human diseases through microbiome-based solutions.

1 investor

GeniPhys develops Collymer, a patented polymerizable (scaffold-forming) collagen technology used to design and fabricate collagen biomaterials for tissue restoration and regeneration. Its materials target regenerative medicine applications including soft tissue, cardiovascular, musculoskeletal, and orthopedic replacements, as well as delivery of pharmaceutical and cell-based therapies and device coatings.

1 investor

GeniusVets provides a marketing program for veterinary practices, including websites, search engine marketing, content, and a directory that helps pet owners find local vets. It serves veterinarians and veterinary clinics in the animal health industry.

1 investor

Genomadix develops the Cube, a point-of-care PCR platform for real-time molecular testing in precision medicine and environmental applications. The company commercializes FDA-cleared genotyping tests and offers its open platform for partnerships with assay developers and clinical laboratories.

1 investor

Genomate Health develops an AI-powered clinical decision support system for precision oncology that analyzes a patient's molecular profile to produce evidence-based treatment rankings for physicians. Its Genomate platform combines oncology, genomics, and computational reasoning to support personalized cancer treatment decisions.

1 investor

Genome Medical provides telehealth-enabled genetic counseling, testing, and clinical trial access for patients with rare diseases. The company partners with hospitals, health systems, and life sciences organizations to deliver expert genetic services at scale.

1 investor

GenoME develops liquid biopsy tests using DNA methylation biomarkers for early disease detection and monitoring, particularly in cancer diagnostics. The company's pipeline identifies novel biomarkers and delivers rapid, cost-effective PCR tests for applications including companion diagnostics and disease monitoring.

1 investor

Genomics is a genetics company that uses polygenic risk scores and DNA analysis to predict an individual's risk of common diseases, offering risk assessment tools through a single at-home test. It serves insurance and other partners, employers, life sciences and pharmaceutical companies, and healthcare systems for disease prediction, drug discovery, and precision health.

1 investor

GenomILL develops precision diagnostic technologies using genomic analysis. The company serves clinical and research customers seeking advanced molecular diagnostics.

1 investor